Astena Holdings Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3150000002
JPY
490.00
5 (1.03%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

The company has declared Negative results for the last 3 consecutive quarters

  • DEBT-EQUITY RATIO (HY) Highest at 48.91 %
  • INTEREST(Q) Highest at JPY 119 MM
2

With ROCE of 7.66%, it has a very attractive valuation with a 0.82 Enterprise value to Capital Employed

3

Underperformed the market in the last 1 year

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

JPY 19,973 Million (Small Cap)

stock-summary
P/E

8.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.20%

stock-summary
Debt Equity

0.49

stock-summary
Return on Equity

8.80%

stock-summary
Price to Book

0.72

Revenue and Profits:
Net Sales:
16,557 Million
(Quarterly Results - Feb 2026)
Net Profit:
589 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
1.45%
0%
1.45%
6 Months
5.38%
0%
5.38%
1 Year
4.03%
0%
4.03%
2 Years
1.66%
0%
1.66%
3 Years
8.41%
0%
8.41%
4 Years
12.64%
0%
12.64%
5 Years
-26.87%
0%
-26.87%

Astena Holdings Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-0.81%
EBIT Growth (5y)
8.21%
EBIT to Interest (avg)
21.22
Debt to EBITDA (avg)
1.74
Net Debt to Equity (avg)
0.37
Sales to Capital Employed (avg)
1.29
Tax Ratio
100.00%
Dividend Payout Ratio
33.19%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.25%
ROE (avg)
6.80%

Valuation key factors

Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
0.73
EV to EBIT
10.66
EV to EBITDA
6.55
EV to Capital Employed
0.82
EV to Sales
0.51
PEG Ratio
0.37
Dividend Yield
0.21%
ROCE (Latest)
7.66%
ROE (Latest)
8.76%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Feb'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Feb 2026 is -4.11% vs 12.31% in Nov 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Feb 2026 is 6.90% vs 58.79% in Nov 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Feb'26",
        "Nov'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "16,557.00",
          "val2": "17,267.00",
          "chgp": "-4.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,805.00",
          "val2": "880.00",
          "chgp": "105.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "119.00",
          "val2": "56.00",
          "chgp": "112.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-13.00",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "589.00",
          "val2": "551.00",
          "chgp": "6.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "69.60%",
          "val2": "12.50%",
          "chgp": "5.71%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Nov'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Nov 2025 is 8.19% vs 11.56% in Nov 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Nov 2025 is 185.86% vs -320.06% in Nov 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Nov'25",
        "Nov'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "62,744.00",
          "val2": "57,993.40",
          "chgp": "8.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5,446.00",
          "val2": "5,402.90",
          "chgp": "0.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "220.00",
          "val2": "88.60",
          "chgp": "148.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-279.00",
          "val2": "-4,525.70",
          "chgp": "93.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,179.00",
          "val2": "-2,538.00",
          "chgp": "185.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "48.10%",
          "val2": "48.60%",
          "chgp": "-0.05%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Feb'26 - QoQstock-summary

Feb'26
Nov'25
Change(%)
Net Sales
16,557.00
17,267.00
-4.11%
Operating Profit (PBDIT) excl Other Income
1,805.00
880.00
105.11%
Interest
119.00
56.00
112.50%
Exceptional Items
0.00
-13.00
100.00%
Consolidate Net Profit
589.00
551.00
6.90%
Operating Profit Margin (Excl OI)
69.60%
12.50%
5.71%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Feb 2026 is -4.11% vs 12.31% in Nov 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Feb 2026 is 6.90% vs 58.79% in Nov 2025

Annual Results Snapshot (Consolidated) - Nov'25stock-summary

Nov'25
Nov'24
Change(%)
Net Sales
62,744.00
57,993.40
8.19%
Operating Profit (PBDIT) excl Other Income
5,446.00
5,402.90
0.80%
Interest
220.00
88.60
148.31%
Exceptional Items
-279.00
-4,525.70
93.84%
Consolidate Net Profit
2,179.00
-2,538.00
185.86%
Operating Profit Margin (Excl OI)
48.10%
48.60%
-0.05%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Nov 2025 is 8.19% vs 11.56% in Nov 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Nov 2025 is 185.86% vs -320.06% in Nov 2024

stock-summaryCompany CV
About Astena Holdings Co., Ltd. stock-summary
stock-summary
Astena Holdings Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available